文献

J-GLOBAL ID：201902216505961709   整理番号：19A2308220

糖尿病性腎疾患の治療における抗炎症に対する熱除去特性を有するハーブ薬の応用【JST・京大機械翻訳】

Application of Herbal Medicines with Heat-Clearing Property to Anti-Microinflammation in the Treatment of Diabetic Kidney Disease

著者 (7件)： Guo Jing (Renal Research Institution, Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China) ,  Gao Yabin ( Department of Nephrology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, 5 Haiyuncang, Dongcheng District, Beijing 100700, China) ,  Wang Yaoxian (Renal Research Institution, Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China) ,  Wang Yaoxian ( Department of Nephrology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, 5 Haiyuncang, Dongcheng District, Beijing 100700, China) ,  Liu Wei Jing (Renal Research Institution, Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China) ,  Zhou Jingwei ( Department of Nephrology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, 5 Haiyuncang, Dongcheng District, Beijing 100700, China) ,  Wang Zhen ( Department of Nephrology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, 5 Haiyuncang, Dongcheng District, Beijing 100700, China)
資料名： Evidence-Based Complementary and Alternative Medicine (Web)  (Evidence-Based Complementary and Alternative Medicine (Web))
巻： 2019  ページ： Null  発行年： 2019年 
JST資料番号： U7703A  ISSN： 1741-427X  資料種別： 逐次刊行物 (A)
記事区分： 文献レビュー  発行国： イギリス (GBR)  言語： 英語 (EN)

抄録/ポイント： 糖尿病性腎疾患(DKD)は世界的なパンデミックであり,微小炎症はDKDの重要な病原因子として報告されている。伝統的漢方薬(TCM)は数千年にわたりDKDの治療に使用されており,現代の漢方薬研究は,熱除去特性を有する漢方薬がDKDにおいて治療的抗炎症効果を有することを見出している。本論文では,DKDの治療において,またそれらの安全性側面と同様に,熱除去特性を有する漢方薬において行われた新しい臨床的および実験的進歩についてレビューした。Copyright 2019 Jing Guo et al. Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： *糖尿病性腎症 ,  安全性 ,  漢方製剤 ,  ヒト ,  *治療法 ,  *薬物療法 ,  *ハーブ ,  *消炎作用 ,  *熱除去
準シソーラス用語： 病原因子 ,  微小炎症 , 【Automatic Indexing@JST】

分類 (2件)： 泌尿生殖器疾患の薬物療法  (GM05020V) ,  代謝異常・栄養性疾患の治療  (GD05030F)

引用文献 (40件)：

• International Diabetes Federation, IDF Diabetes Altas Globally, 8th edition, 2017.
• K. R. Tuttle, G. L. Bakris, R. W. Bilous, J. L. Chiang, I. H. de Boer, J. Goldstein-Fuchs, I. B. Hirsch, K. Kalantar-Zadeh, A. S. Narva, S. D. Navaneethan, J. J. Neumiller, U. D. Patel, R. E. Ratner, A. T. Whaley-Connell, M. E. Molitch, "Diabetic kidney disease: a report from an ADA Consensus Conference," American Journal of Kidney Diseases, vol. 64, no. 4, pp. 510-533, 2014.
• T. Guoyu, Z. Dalong, "Interpretation of clinical practice guidelines and expert consensuses for the evaluation and management of diabetic kidney disease at home and abroad," Chinese Journal of Practical Internal Medicine, vol. 37, no. 03, pp. 211-216, 2017.
• H. Chen, J. Guo, X. Zhao, X. He, Z. He, L. Zhao, X. Tong, "Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years," Medicine (United States), vol. 96, no. 12, pp. e6349, 2017.
• W.-J. Huang, T. Yang, C.-J. Liu et al., "Traditional Chinese medicine based on Zheng differentiation versus angiotensin receptor blocker/angiotensin-converting enzyme antagonist in efficacy of treating diabetic kidney disease: A meta-analysis of randomized clinical trials," World Journal of Traditional Chinese Medicine, vol. 5, no. 1, pp. 18-28, 2019.

タイトルに関連する用語 (6件)： 糖尿病性腎疾患 ,  治療 ,  抗炎症 ,  熱除去 ,  ハーブ ,  応用